Home › Funds › Viking Global Investors › NTLA
Viking Global Investors position in NTLA
INTELLIA THERAPEUTICS INC · Health Care
Latest position (Q1 2023)1.57M sh
Reported value held$58.50M
Portfolio Weight0.28%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 1.28M | $171.65M | New |
| Q4 2021 | 1.58M | $186.76M | Add |
| Q1 2022 | 2.47M | $179.41M | Add |
| Q2 2022 | 2.23M | $115.34M | Reduce |
| Q3 2022 | 1.89M | $105.71M | Reduce |
| Q4 2022 | 2.02M | $70.53M | Add |
| Q1 2023 | 1.57M | $58.50M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding NTLA
- ARK Invest 16.88M sh · $285.54M · Q2 2026
- BlackRock Inc 15.41M sh · $260.72M · Q2 2026
- Vanguard Group 13.01M sh · $116.96M · Q4 2025
- D. E. Shaw & Co 6.44M sh · $109.02M · Q2 2026
- Two Sigma Investments 5.24M sh · $88.58M · Q2 2026
- Fidelity Management & Research (FMR) 4.77M sh · $80.76M · Q2 2026
- Geode Capital Management 3.63M sh · $61.45M · Q2 2026
- Arrowstreet Capital 3.28M sh · $55.51M · Q2 2026
- UBS Group AG 2.45M sh · $41.39M · Q2 2026
- Goldman Sachs Group 2.26M sh · $38.31M · Q2 2026
- Morgan Stanley 1.73M sh · $29.30M · Q2 2026
- Renaissance Technologies 1.40M sh · $23.69M · Q2 2026